SMAD3 and hepatocellular carcinoma: Moreover, we have previously shown that core protein extracted from HCV/HCC tumor tissue could bind Smad3 in GST-pull down analyses [27] suggesting that perturbation of TGF-β signaling may also be modulated in vivo.